BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,067 filers reported holding BAXTER INTL INC in Q2 2018. The put-call ratio across all filers is 0.99 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,438,977 | -30.2% | 38,129 | -25.0% | 0.00% | 0.0% |
| Q1 2023 | $2,061,786 | -51.2% | 50,833 | -38.7% | 0.00% | -55.6% |
| Q4 2022 | $4,227,962 | -18.9% | 82,950 | -14.3% | 0.01% | -35.7% |
| Q3 2022 | $5,212,000 | +2.7% | 96,778 | +22.5% | 0.01% | +7.7% |
| Q2 2022 | $5,074,000 | -17.7% | 78,999 | -0.6% | 0.01% | 0.0% |
| Q1 2022 | $6,162,000 | +6.0% | 79,467 | +17.3% | 0.01% | 0.0% |
| Q4 2021 | $5,814,000 | +10.1% | 67,731 | +3.1% | 0.01% | 0.0% |
| Q3 2021 | $5,282,000 | +7.8% | 65,667 | +7.9% | 0.01% | 0.0% |
| Q2 2021 | $4,900,000 | -13.3% | 60,864 | -9.1% | 0.01% | -27.8% |
| Q1 2021 | $5,650,000 | +20.5% | 66,985 | +14.6% | 0.02% | +20.0% |
| Q4 2020 | $4,690,000 | +6.5% | 58,446 | +6.7% | 0.02% | -11.8% |
| Q3 2020 | $4,405,000 | -7.8% | 54,776 | -1.3% | 0.02% | -22.7% |
| Q2 2020 | $4,780,000 | +4.6% | 55,514 | -1.3% | 0.02% | -15.4% |
| Q1 2020 | $4,568,000 | -6.2% | 56,260 | -3.4% | 0.03% | +18.2% |
| Q4 2019 | $4,869,000 | -7.1% | 58,223 | -2.8% | 0.02% | -18.5% |
| Q3 2019 | $5,239,000 | +10.2% | 59,895 | +3.1% | 0.03% | +3.8% |
| Q2 2019 | $4,756,000 | -9.8% | 58,074 | -10.5% | 0.03% | -7.1% |
| Q1 2019 | $5,275,000 | +23.7% | 64,880 | +0.2% | 0.03% | +7.7% |
| Q4 2018 | $4,263,000 | -19.6% | 64,769 | -5.9% | 0.03% | 0.0% |
| Q3 2018 | $5,304,000 | -3.2% | 68,803 | -7.3% | 0.03% | -16.1% |
| Q2 2018 | $5,480,000 | +20.5% | 74,205 | +6.1% | 0.03% | 0.0% |
| Q1 2018 | $4,547,000 | -0.8% | 69,913 | -1.4% | 0.03% | +3.3% |
| Q4 2017 | $4,583,000 | +11.7% | 70,908 | +8.4% | 0.03% | 0.0% |
| Q3 2017 | $4,104,000 | +6.7% | 65,390 | +2.9% | 0.03% | +3.4% |
| Q2 2017 | $3,846,000 | +9.1% | 63,531 | -6.6% | 0.03% | +7.4% |
| Q1 2017 | $3,526,000 | +29.0% | 67,991 | +10.3% | 0.03% | +12.5% |
| Q4 2016 | $2,734,000 | -24.5% | 61,646 | -19.0% | 0.02% | -29.4% |
| Q3 2016 | $3,622,000 | +0.5% | 76,086 | -4.6% | 0.03% | -2.9% |
| Q2 2016 | $3,605,000 | +19.8% | 79,717 | +8.8% | 0.04% | +20.7% |
| Q1 2016 | $3,010,000 | -6.6% | 73,264 | -13.3% | 0.03% | -12.1% |
| Q4 2015 | $3,224,000 | +20.4% | 84,497 | +3.6% | 0.03% | -2.9% |
| Q3 2015 | $2,678,000 | -70.1% | 81,526 | -36.4% | 0.03% | -67.0% |
| Q2 2015 | $8,970,000 | -6.9% | 128,279 | -8.8% | 0.10% | -6.4% |
| Q1 2015 | $9,634,000 | -5.1% | 140,643 | +1.5% | 0.11% | -9.1% |
| Q4 2014 | $10,155,000 | +5.2% | 138,552 | +3.0% | 0.12% | -2.4% |
| Q3 2014 | $9,649,000 | +9.7% | 134,453 | +10.5% | 0.12% | -16.2% |
| Q2 2014 | $8,794,000 | +0.8% | 121,628 | +2.6% | 0.15% | -6.9% |
| Q1 2014 | $8,722,000 | +26.4% | 118,539 | +19.4% | 0.16% | +14.4% |
| Q4 2013 | $6,903,000 | +23.0% | 99,256 | +16.2% | 0.14% | +9.4% |
| Q3 2013 | $5,612,000 | +5.6% | 85,433 | +11.4% | 0.13% | -3.1% |
| Q2 2013 | $5,312,000 | – | 76,682 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
| Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
| NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
| PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
| Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
| Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
| Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
| Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
| Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
| Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |